Skip to main content
TipRanks
Go Ultimate75% OFF

Santhera Pharmaceuticals Holding (SANN) Q2 2024 Earnings Report

6 Followers

CH:SANN Q2 2024 EPS Results

Actual EPS
-CHF 1.35
Consensus EPS
-CHF 0.94
Beat/Miss
Missed by -CHF 0.41
One Year Ago EPS
-CHF 1.58

CH:SANN Q2 2024 Revenue Results

Actual Revenue
CHF 14.11M
Expected Revenue
CHF 10.30M
Beat/Miss
Beat by +CHF 3.81M
YoY Revenue Growth
+258.31%

Earnings Announcement Details

Quarter
Q2 2024
Date
09/12/2024
Time
Before Open
Conference Call
Thursday, September 12, 2024
CH:SANN Upcoming Earnings

Santhera Pharmaceuticals Holding's next earnings date is estimated for April 29, 2027, based on past reporting schedules.

Q2 2024 Earnings Call Audio

CH:SANN Q2 2024 Earnings Call
0:00 / 0:00

Q2 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:SANN Earnings History

CH:SANN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 29, 20272026 (Q4)―--0.43――
Sep 30, 20262026 (Q2)0.17-1.50-0.37-305.41% (-1.13)
Apr 28, 20262025 (Q4)-0.43-0.43-0.7441.89% (+0.31)
Sep 23, 20252025 (Q2)-0.60-3.04-1.35-125.19% (-1.69)
Apr 29, 20252024 (Q4)-0.74-0.747.27-110.18% (-8.01)
Sep 12, 20242024 (Q2)-0.94-1.35-1.5814.56% (+0.23)
Apr 25, 20242023 (Q4)―7.27-2.13441.31% (+9.40)
Sep 07, 20232023 (Q2)-1.58-1.58-5.2469.85% (+3.66)
Apr 27, 20232022 (Q4)―-2.13-2.37.39% (+0.17)
Oct 31, 20222022 (Q2)―-5.24-9.2243.19% (+3.98)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed